tiprankstipranks
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Want to see CH:SANN full AI Analyst Report?

Compare Santhera Pharmaceuticals Holding (SANN) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
CHF17.62
CHF244.53M
-4.06
29.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF117.49M
-2.23
-12.27%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF656.04M
6.84
19.10%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF1.06B
-4.80
188.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.44
CHF293.78M
-9.69
80.69%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.90
CHF117.66M
3.92
2.43%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:SANN
Santhera Pharmaceuticals Holding
16.46
3.82
30.22%
CH:MOLN
Molecular Partners AG
2.86
-0.44
-13.33%
CH:BSLN
Basilea Pharmaceutica
53.00
7.75
17.13%
CH:IDIA
Idorsia Ltd
3.97
2.51
170.94%
CH:NWRN
Newron Pharmaceuticals SpA
14.22
6.50
84.20%
CH:XLS
Xlife Sciences Ltd.
21.10
1.00
4.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts